Analyst Activity – Cann Reiterates Buy on Epizyme (NASDAQ:EPZM)

ME Staff
-
0

Analyst Ratings For Epizyme (NASDAQ:EPZM)

Today, Cann reiterated its Buy rating on Epizyme (NASDAQ:EPZM) with a price target of $26.00.

There are 10 buy ratings on the stock.

The current consensus rating on Epizyme (NASDAQ:EPZM) is Buy (Score: 3.00) with a consensus target price of $24.43 per share, a potential 36.85% upside.

Some recent analyst ratings include

  • 9/19/2017-Cann Reiterated Rating of Buy.
  • 9/15/2017-Royal Bank Of Canada Reiterated Rating of Buy.
  • 8/9/2017-Leerink Swann Reiterated Rating of Outperform.
  • 8/7/2017-HC Wainwright Reiterated Rating of Buy.
  • 6/7/2017-Cowen and Company Reiterated Rating of Buy.

Recent Insider Trading Activity For Epizyme (NASDAQ:EPZM)
Epizyme (NASDAQ:EPZM) has insider ownership of 25.20% and institutional ownership of 83.74%.

  • On 9/18/2017 David M Mott, Director, bought 200,000 with an average share price of $15.25 per share and the total transaction amounting to $3,050,000.00. View SEC Filing
  • On 8/24/2017 Peter Tai-Ching Ho, Insider, sold 15,000 with an average share price of $15.68 per share and the total transaction amounting to $235,200.00. View SEC Filing
  • On 7/24/2017 Peter Tai-Ching Ho, Insider, sold 15,000 with an average share price of $13.44 per share and the total transaction amounting to $201,600.00. View SEC Filing
  • On 6/30/2017 Andrew E Singer, CFO, sold 3,024 with an average share price of $15.50 per share and the total transaction amounting to $46,872.00. View SEC Filing
  • On 6/26/2017 Peter Tai-Ching Ho, Insider, sold 15,000 with an average share price of $14.87 per share and the total transaction amounting to $223,050.00. View SEC Filing
  • On 6/6/2017 Robert A Copeland, Insider, sold 2,500 with an average share price of $13.45 per share and the total transaction amounting to $33,625.00. View SEC Filing
  • On 5/25/2017 Peter Tai-Ching Ho, Insider, sold 15,000 with an average share price of $16.11 per share and the total transaction amounting to $241,650.00. View SEC Filing

Recent Trading Activity for Epizyme (NASDAQ:EPZM)
Shares of Epizyme closed the previous trading session at with shares trading hands.